Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Strategic Asset Allocation Index
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Strategic Asset Allocation Index of 38.0% as of June 2023. Strategic assets (PP&E of CN¥3.31 Billion plus long-term investments of CN¥-) total CN¥3.31 Billion, measured against net assets of CN¥8.72 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 300026 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Tianjin Chase Sun Pharmaceutical Co Ltd Strategic Asset Allocation Index (2006–2021)
This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2006 to 2021. As of June 2023, the index stands at 38.0%, representing strategic assets of CN¥3.31 Billion against net assets of CN¥8.72 Billion CNY. See Tianjin Chase Sun Pharmaceutical Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2021, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 300026 market cap.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 36.5% | CN¥2.90 Billion | CN¥2.90 Billion | CN¥- | CN¥7.95 Billion | ▲ +1.9 pp |
| 2020 | 34.6% | CN¥2.56 Billion | CN¥2.56 Billion | CN¥- | CN¥7.39 Billion | ▲ +2.0 pp |
| 2019 | 32.6% | CN¥2.31 Billion | CN¥2.31 Billion | CN¥- | CN¥7.07 Billion | ▲ +0.9 pp |
| 2018 | 31.7% | CN¥2.08 Billion | CN¥1.80 Billion | CN¥281.52 Million | CN¥6.58 Billion | ▲ +3.3 pp |
| 2017 | 28.4% | CN¥1.85 Billion | CN¥1.58 Billion | CN¥273.62 Million | CN¥6.51 Billion | ▲ +1.8 pp |
| 2016 | 26.7% | CN¥1.61 Billion | CN¥1.37 Billion | CN¥235.55 Million | CN¥6.04 Billion | ▲ +4.6 pp |
| 2015 | 22.1% | CN¥1.17 Billion | CN¥1.13 Billion | CN¥43.16 Million | CN¥5.29 Billion | ▼ -9.7 pp |
| 2014 | 31.8% | CN¥749.15 Million | CN¥749.15 Million | CN¥- | CN¥2.36 Billion | ▼ -11.2 pp |
| 2013 | 42.9% | CN¥731.17 Million | CN¥731.17 Million | CN¥- | CN¥1.70 Billion | ▼ -7.7 pp |
| 2012 | 50.6% | CN¥702.07 Million | CN¥702.07 Million | CN¥- | CN¥1.39 Billion | ▲ +13.4 pp |
| 2011 | 37.2% | CN¥390.79 Million | CN¥390.79 Million | CN¥- | CN¥1.05 Billion | ▲ +18.2 pp |
| 2010 | 19.0% | CN¥208.23 Million | CN¥208.23 Million | CN¥- | CN¥1.10 Billion | ▲ +5.9 pp |
| 2009 | 13.0% | CN¥120.89 Million | CN¥120.89 Million | CN¥- | CN¥926.88 Million | ▼ -53.9 pp |
| 2008 | 66.9% | CN¥84.02 Million | CN¥84.02 Million | CN¥- | CN¥125.51 Million | ▼ -7.1 pp |
| 2007 | 74.1% | CN¥45.37 Million | CN¥45.37 Million | CN¥- | CN¥61.24 Million | ▼ -119.6 pp |
| 2006 | 193.7% | CN¥41.21 Million | CN¥41.21 Million | CN¥- | CN¥21.28 Million | — |